Dear HIFA Colleagues,
As the Healthcare Information For All (HIFA) Country Representative for Nigeria, I would like to submit the following insights regarding the cervical cancer prevention landscape in my country. These observations address our active discussion highlighting the structural realities, cultural barriers and policy developments within our healthcare system.
1. What is one thing about cervical cancer in your country that people in other countries might find surprising?
International observers are frequently surprised to learn that despite pervasive digital misinformation campaigns and historical public health trust deficits, Nigeria successfully orchestrated a massive, phased national rollout of the single-dose Human Papillomavirus (HPV) vaccine starting in late 2023. Backed by the National Primary Health Care Development Agency (NPHCDA) and global health partners, the country has vaccinated over 18 million adolescent girls aged 9–14, achieving approximately 76% coverage of the primary target population. This milestone underscores the capacity of sub-Saharan health systems to achieve immense scale when high-level political commitment aligns with localized community mobilization.
2. What is one thing you wish every girl knew about cervical cancer before reaching adulthood?
It is vital for every adolescent girl to understand that cervical cancer is almost entirely preventable through primary HPV vaccination, and that also acquiring HPV is a common medical occurrence rather than a source of moral shame. Equipping young women with the knowledge that early prevention completely shifts their long-term health trajectory can effectively demystify the disease and empower them to make proactive healthcare decisions long before adulthood.
3. Is cervical cancer still regarded as a taboo subject in your country? If so, what are the consequences?
Yes, across many conservative and rural Nigerian communities, cervical cancer remains heavily stigmatized due to its association with sexual transmission. This socio-cultural taboo drives profound clinical consequences: women routinely conceal initial symptoms out of fear of social ostracization, marital alienation, or accusations of infidelity. Consequently, an estimated 90% of cervical cancer patients present to tertiary healthcare facilities at late, advanced stages (Stage III or IV), where treatment options are severely limited and mortality rates are high.
4. Who do women trust most for information about cervical cancer, and where do they actually get their information?
While urban, literate populations increasingly turn to social media and digital channels for health information thus leaving them highly vulnerable to coordinated anti-vaccine rhetoric, the absolute arbiters of trust remain traditional rulers, healthcare professionals, and religious institutions (both Christian and Islamic). In practice, however, a gap persists: many women still rely on informal peer-to-peer networks, family members, or local marketplaces for health updates, where unverified medical misconceptions frequently eclipse empirical scientific guidance.
5. If you could change just one thing about cervical cancer prevention in your country, what would it be?
I would transition our national secondary prevention strategy away from an opportunistic, fragmented model and fully decentralize affordable "screen-and-treat" protocols directly into our rural Primary Healthcare Centers (PHCs). Our national screening coverage is critically low at just 7.8%. By integrating point-of-care high-performance HPV DNA testing paired with immediate thermal ablation at the grass-roots level, we can mitigate the systemic barriers of cost, travel distance, and severe loss-to-follow-up that currently restrict screening to affluent urban centers.
6. What could be done to help improve understanding of cervical cancer in your country?
We must systematically institutionalize reproductive health education within the junior secondary school curriculum and forge structured alliances with faith-based organizations. When community health advocates partner with religious leaders to discuss vaccine safety and screening openly from the pulpit and within mosques, it directly dismantles socio-cultural taboos, counters vaccine hesitancy, and normalizes life-saving, preventative healthcare-seeking behaviors across diverse populations.
I look forward to discussing how other member nations are addressing sub-national policy gaps, managing healthcare worker limitations, and refining communication strategies to meet the World Health Organization’s 90-70-90 cervical cancer elimination targets.
Warm regards,
Nnamdi Umelo
HIFA Country Representative, Nigeria
References
- National Primary Health Care Development Agency (NPHCDA). (2026). Strategic Update on Phased National Single-Dose HPV Vaccination Program. Federal Ministry of Health and Social Welfare, Abuja, Nigeria.
- Nigeria Tribune. (2026). Nigeria records 7.8% cervical cancer screening uptake in regional analysis. Published November 9, 2026.
- Union for International Cancer Control (UICC). (2026). Nigeria's path to cervical cancer elimination: Challenges, data, and people. UICC Global Policy Briefings.
- Odetola, T. D., et al. (2026). Knowledge, screening uptake, and structural barriers to cervical cancer prevention among women of reproductive age in Nigeria: A systematic review. International Journal of Global Health and Epidemiology, 14(3), 210-224.
- Punch Healthwise. (2026). Nigeria crossing 18 million adolescent girls milestone in routine immunisation]. Published September 29, 2026.
HIFA profile: Nnamdi Umelo is a 5th Year Medical Student at Usmanu Danfodiyo University, Sokoto, Nigeria. I have a strong interest in cancer research, public health, and global health policy. I believe that limited access to accurate, evidence based health information remains a major contributor to preventable illness and death, particularly in rural and underserved communities across Africa. I am passionate about health advocacy, promoting health literacy, and supporting equitable access to reliable healthcare information. Through HIFA, I hope to learn from a global network of professionals, contribute to discussions on improving access to health information, collaborate on research and advocacy initiatives, and apply the knowledge gained to strengthen health education and cancer awareness in my community and beyond. Nnamdi Umelo is a HIFA country representative for Nigeria. https://www.hifa.org/support/members/nnamdi nnamdiumelo799 AT gmail.com